Matthias Egger is the President of the National Research Council at the Swiss National Science Foundation (SNSF). Since 2002, Matthias Egger has been a professor of epidemiology and public health at the University of Bern. Until 2016, he headed the university’s Institute of Social and Preventive Medicine. He has also been a Professor of Clinical Epidemiology at the University of Bristol in the UK since 2002. In 2017 he was elected President of the National Research Council of the SNSF. Between April and July 2020, he led the scientific task force advising the Swiss government on the COVID-19 pandemic. He is currently working on projects involving vaccination against Ebola, studies on HIV/AIDS, tuberculosis, and cancer in southern Africa, as well as methodological projects.

André Kudelski is President of the Board of Innosuisse, the Swiss Innovation Agency whose role is to promote science-based innovation in the interests of industry and society in Switzerland. He also serves as Chairman and Chief Executive Officer of the Kudelski Group, a leading technology company listed on the SIX Swiss Exchange (SIX: KUD:S). As part of a Swiss delegation to the White House in 2015, the Kudelski Group committed to introducing its successful Swiss apprenticeship program to its U.S. facilities, and in 2018, the Group signed the Pledge to America’s Workers, committing to provide training opportunities over the next five years. Mr. Kudelski started his career with the Group in 1984 as a Research and Development engineer and in 1989 became Managing Director of Nagravision, its pay-TV division. In 1991, he succeeded his father to the position of Chairman and CEO. In addition, André Kudelski serves as Vice-Chairman of the Swiss-American Chamber of Commerce and is a member of the Supervisory Board of Publicis Groupe. He is a member of the Strategic Advisory Board of École Polytechnique Fédérale de Lausanne (EPFL) as well as a committee member of economiesuisse and Chairman of the Advisory Board of the Ecole Cantonale d’Art de Lausanne (ECAL). He is also a member of the Swiss Academy of Technical Sciences and a member of the Board of Directors and Executive Committee of the Greater Phoenix Economic Council.
Previously, Mr. Kudelski served as Vice-Chairman of the Geneva International Airport and on the boards of directors of Nestlé SA, HSBC Private Banking Holdings (Suisse), Edipresse SA and Dassault Systèmes SA.
André Kudelski holds a Master of Science (MSc) in Applied Physics from the École Polytechnique Fédérale de Lausanne and has also received honors, including as a “Global Leader for Tomorrow” by the World Economic Forum in 1995 and an Emmy® Award from the US National Academy of Arts and Sciences for achievements in the area of pay-TV conditional access and scrambling systems in 1996. He is a regular speaker at the World Economic Forum’s Annual Meeting in Davos, Switzerland and the Science and Technology in Society Forum in Kyoto, Japan.

As Head of Innovation, Alicia works to connect Switzerland’s startups, innovation-driven companies, and foundations with game-changing partners and ideas in the US. Prior to joining Swissnex, Alicia worked in technology transfer at the National Institutes of Health, and as an open innovation consultant at yet2 in the Boston area. Alicia holds a PhD in Molecular Medicine from Boston University and a BS in biomedical engineering from the University of Virginia.

Lan Zuo Gillet is the Deputy Managing Director of EPFL Innovation Park and an Expert of Innosuisse – the Swiss Innovation Agency. She has 23 years of hands-on professional experience in the industry as well as in the ecosystem of innovation & entrepreneurship.

Lan started her career at R&D department of Rolex, in charge of creating new computer aided design and optimization tools in the product development process. She was later appointed as Head of Operational Planning at Pictet, working closely with a startup to design, develop and implement a management information system for group operation control. As the Managing Director of Geneva Creativity Center, she connected large corporations, SMEs, startups, and researchers to initiate innovative joint R&D projects.

Currently, at EPFL Innovation Park, she is leading entrepreneurship training and acceleration programs and is helping startups to establish business partnerships with large corporations. Lan has a PhD degree from EPFL, an MBA from HEC Lausanne, and postdoctoral applied research experience at Stanford University.

Ksenia Tugay is a Strategic Innovation Expert at Groupe Mutuel, a leading Swiss Health Insurance. Apart from leading Tech4Eva, Ksenia is responsible for identifying start-ups, trends, and best practices of strategic interest to Groupe Mutuel. Ksenia holds PhD in Life Sciences from the University of Lausanne. Her PhD was dedicated to Type 2 Diabetes, Genetics, and Ageing. After completing her PhD, Ksenia has joined Inartis Foundation and was instrumental in launching the first edition of the MassChallenge startup acceleration program in Switzerland. Throughout her career, Ksenia worked with key Swiss startup accelerators and incubators in Switzerland including Impact Hub and Swiss EdTech Collider.

Nicole C. Woitowich, PhD is a biomedical scientist whose research, interests, and passion focuses on women’s health and the advancement of women in science and medicine. She is actively transforming the landscape of the biomedical research enterprise through her research, advocacy, and outreach activities.

Christa Moss is Maven’s VP of Clinical & Payer Strategy, leading Maven’s Clinical Strategy and Research & Outcomes team to drive improved outcomes through Maven’s digital-first care model, in addition to working closely with payers and other healthcare partners.

She joined Maven after spending 8+ years at McKinsey & Company, where she served as a Senior Expert and Associate Partner in the Cleveland Office. At McKinsey, she was a leader in the Healthcare Systems and Services (HSS) practice and McKinsey Healthcare Analytics. During her time there, Christa developed significant expertise in the areas of maternal health, value-based care, Medicaid, and healthcare analytics — leading the design of maternity episodes of care across multiple payers and state Medicaid programs, including innovations such as the incorporation of social determinants of health in risk adjustment models as well as neonatal outcomes in quality assessment. Christa also led maternal health work in the private equity space.

Prior to her work at McKinsey, Christa started her career in clinical research, receiving her Ph.D. in Biomedical Engineering from Case Western Reserve University. She also has a B.S. in Biomedical Engineering from the University of North Carolina at Chapel Hill and she now lives in Cleveland, Ohio with her husband and two young daughters.

Alice Zheng has been a women’s health enthusiast throughout her career spanning global health, clinical medicine, and the private sector. She is currently a Principal at Rhia Ventures, a women’s health-focused impact fund, leading investments in innovative women’s health companies. Alice was previously a women’s health practice leader and management consultant at McKinsey & Company, where she served biopharma, diagnostics, global public health, and private equity clients across R&D and commercial strategy topics.

Earlier in her career, Alice’s passion to improve lives for the underserved led her to work in East Africa and Asia in reproductive health and family planning with EngenderHealth, Marie Stopes International, and other nonprofits. As a clinician, she focused on women’s health globally and published articles examining healthcare in low-income countries.

Alice holds an MBA from Harvard Business School and MD and MPH from the University of Michigan, where she was a Dean’s Merit Scholar. Alice is a frequent speaker on FemTech and women’s health innovation and is a steering committee member for multiple women’s health innovation forums.

Entrepreneur, investor, world-traveler, scientist, and running-enthusiast living in Boston, MA. Harvard University ’18 graduate in Molecular Biology with a secondary in Global Health.

Oriana has global experience creating and leading teams and organizations resulting in successful strategic exits. ​She brings a wealth of knowledge and expertise from women’s health startups and large life science companies, and a passion for entrepreneurship and solving problems that disproportionately affect women. Recognized for her inspirational leadership, Oriana is known for developing a highly productive culture and turning visions into reality.
Alongside her leadership qualities, Oriana has a proven technical record of creating market entry strategies and product launches in new markets alongside driving market share growth in existing diagnostic assay and instrument markets. Oriana is responsible for building and leading the AOA team, fundraising, and developing and executing long-term strategies. Oriana holds a degree from Boston University in Economics and International Relations, and she has experience both living and working in various geographies.

Brittany Barreto is a geneticist who launched the first nationwide DNA-based dating app (Pheramor). The company ultimately closed but she learned a lot! Next, she was Senior Venture Associate at Capital Factory, the most active venture fund in Texas. she was tasked with opening their Houston branch and had a blast doing it. In 2019 she discovered an industry called FemTech and learned about the grave inequalities in women’s health. In March 2020, during the covid-19 lockdown, she started a FemTech podcast and gained international traction overnight. Now she talks about vulvas full time via her 501c3 non-profit, FemTech Focus! She launched a US-based seed-stage venture fund called Coyote Ventures and advise other women’s health funds on investing in stellar FemTech startups